Beta Bionics, Inc. Common Stock (BBNX)
Beta Bionics, Inc. Common Stock (BBNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -51 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -60 | -32 | -48 | -51 | |
| 2.1 | 2.1 | 2.3 | 2.9 | |
| 6.1 | 5.7 | 6.4 | 16 | |
| -2.8 | -6.4 | -12 | -9.0 | |
| 0.8 | 0.4 | 3.4 | 5.3 | |
| -0.8 | -70 | -3.5 | -163 | |
| 57 | 101 | 56 | 215 | |
| -4.2 | -1.1 | 3.9 | 1.1 | |
| -61 | -33 | -52 | -56 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.